Dapirolizumab pegol is an investigational Fc-free polyethylene glycol-conjugated antigen-binding fragment that inhibits CD40 ligand signaling.

A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD.

Based on phase 3 trial findings, investigators conclude that transdermal estradiol should be a standard of care ADT option for patients with nonmetastatic prostate cancer. Transdermal estradiol (tE2) ...

Another health care worker who was exposed to a Missouri patient who tested positive for bird flu developed respiratory symptoms.

HealthDay News — Limited data indicate that paternal exposure to antiseizure medications (ASMs) at conception is unlikely to pose any major risk for adverse outcomes for offspring, according to a ...

Primary end point was met, with overall response for 74, 67, and 50 percent receiving axatilimab 0.3 mg, 1 mg, and 3 mg per kilogram of body weight ...

BMA discharge also associated with increases in subsequent emergency department visits and unplanned hospital readmissions.

HealthDay News — For patients with hereditary hemorrhagic telangiectasia (HHT), pomalidomide yields a significant reduction in epistaxis severity, according to a study published in the September 19 ...

Eletriptan most effective for pain freedom at two hours in head-to-head comparisons, followed by rizatriptan, sumatriptan, and zolmitriptan ...

The Food and Drug Administration (FDA) has expanded the approval of Bimzelx ® (bimekizumab-bkzx) to include 3 new indications. In addition to plaque psoriasis, Bimzelx, a humanized interleukin-17A and ...

HealthDay News — COVID-19 vaccine-associated myocarditis (C-VAM) has a mild initial clinical course, but myocardial injury is common, according to a study published online in the October issue of ...

Older adults with long-term benzodiazepine receptor agonist use and insomnia diagnosis had significant improvements in sleep outcomes.